Adipocyte G Protein-Coupled Receptors as Potential Targets for Novel Antidiabetic Drugs
The functional state of adipocytes plays a central role in regulating numerous important metabolic functions, including energy and glucose homeostasis. While white adipocytes store excess calories as fat (triglycerides) and release free fatty acids as a fuel source in times of need, brown and beige...
Gespeichert in:
Veröffentlicht in: | Diabetes (New York, N.Y.) N.Y.), 2023-07, Vol.72 (7), p.825-834 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 834 |
---|---|
container_issue | 7 |
container_start_page | 825 |
container_title | Diabetes (New York, N.Y.) |
container_volume | 72 |
creator | Liu, Liu Wess, Jürgen |
description | The functional state of adipocytes plays a central role in regulating numerous important metabolic functions, including energy and glucose homeostasis. While white adipocytes store excess calories as fat (triglycerides) and release free fatty acids as a fuel source in times of need, brown and beige adipocytes (so-called thermogenic adipocytes) convert chemical energy stored in substrates (e.g., fatty acids or glucose) into heat, thus promoting energy expenditure. Like all other cell types, adipocytes express many G protein-coupled receptors (GPCRs) that are linked to four major functional classes of heterotrimeric G proteins (Gs, Gi/o, Gq/11, and G12/13). During the past few years, novel experimental approaches, including the use of chemogenetic strategies, have led to a series of important new findings regarding the metabolic consequences of activating or inhibiting distinct GPCR/G protein signaling pathways in white, brown, and beige adipocytes. This novel information should guide the development of novel drugs capable of modulating the activity of specific adipocyte GPCR signaling pathways for the treatment of obesity, type 2 diabetes, and related metabolic disorders. |
doi_str_mv | 10.2337/db23-0095 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10281224</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2828913789</sourcerecordid><originalsourceid>FETCH-LOGICAL-c404t-962fa39cf2c8401a8829eca631b32cb0d8865059815b8235d4297abbabd0cb963</originalsourceid><addsrcrecordid>eNpdkUtLxDAUhYMoOj4W_gEJuNFFNcntI1nJMD5BVGREdyFJ0zHSaWrSCv57O46KShZ3cT4OJ3wI7VJyxACK41IzSAgR2QoaUQEiAVY8raIRIZQltBDFBtqM8YUQkg9vHW1AASAggxF6HJeu9ea9s_gC3wXfWdckE9-3tS3xvTW27XyIWEV8N2RN51SNpyrMbBdx5QO-8W-2xuMhKJ3StnMGn4Z-FrfRWqXqaHe-7hZ6OD-bTi6T69uLq8n4OjEpSbtE5KxSIEzFDE8JVZwzYY3KgWpgRpOS8zwjmeA005xBVqZMFEprpUtitMhhC50se9tez21pholB1bINbq7Cu_TKyb9J457lzL9JShinjKVDw8FXQ_CvvY2dnLtobF2rxvo-SsYZhxyyYoHu_0NffB-a4X-flKBQcDFQh0vKBB9jsNXPGkrkwpdc-JILXwO793v-D_ktCD4AHGmQSw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2828913789</pqid></control><display><type>article</type><title>Adipocyte G Protein-Coupled Receptors as Potential Targets for Novel Antidiabetic Drugs</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Liu, Liu ; Wess, Jürgen</creator><creatorcontrib>Liu, Liu ; Wess, Jürgen</creatorcontrib><description>The functional state of adipocytes plays a central role in regulating numerous important metabolic functions, including energy and glucose homeostasis. While white adipocytes store excess calories as fat (triglycerides) and release free fatty acids as a fuel source in times of need, brown and beige adipocytes (so-called thermogenic adipocytes) convert chemical energy stored in substrates (e.g., fatty acids or glucose) into heat, thus promoting energy expenditure. Like all other cell types, adipocytes express many G protein-coupled receptors (GPCRs) that are linked to four major functional classes of heterotrimeric G proteins (Gs, Gi/o, Gq/11, and G12/13). During the past few years, novel experimental approaches, including the use of chemogenetic strategies, have led to a series of important new findings regarding the metabolic consequences of activating or inhibiting distinct GPCR/G protein signaling pathways in white, brown, and beige adipocytes. This novel information should guide the development of novel drugs capable of modulating the activity of specific adipocyte GPCR signaling pathways for the treatment of obesity, type 2 diabetes, and related metabolic disorders.</description><identifier>ISSN: 0012-1797</identifier><identifier>ISSN: 1939-327X</identifier><identifier>EISSN: 1939-327X</identifier><identifier>DOI: 10.2337/db23-0095</identifier><identifier>PMID: 37339353</identifier><language>eng</language><publisher>United States: American Diabetes Association</publisher><subject>Adipocytes ; Adipocytes, Beige - metabolism ; Adipocytes, Brown - metabolism ; Adipocytes, White - metabolism ; Antidiabetics ; Calories ; Diabetes ; Diabetes mellitus (non-insulin dependent) ; Diabetes Mellitus, Type 2 - drug therapy ; Diabetes Mellitus, Type 2 - metabolism ; Drug development ; Energy expenditure ; Energy Metabolism ; Fatty acids ; G protein-coupled receptors ; Glucose - metabolism ; Homeostasis ; Humans ; Hypoglycemic Agents - metabolism ; Hypoglycemic Agents - pharmacology ; Hypoglycemic Agents - therapeutic use ; Metabolic disorders ; Metabolism ; Precision medicine ; Proteins ; Receptors, G-Protein-Coupled - metabolism ; s in Diabetes ; Signal transduction ; Thermogenesis ; Triglycerides</subject><ispartof>Diabetes (New York, N.Y.), 2023-07, Vol.72 (7), p.825-834</ispartof><rights>2023 by the American Diabetes Association.</rights><rights>Copyright American Diabetes Association Jul 2023</rights><rights>2023 by the American Diabetes Association 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c404t-962fa39cf2c8401a8829eca631b32cb0d8865059815b8235d4297abbabd0cb963</citedby><cites>FETCH-LOGICAL-c404t-962fa39cf2c8401a8829eca631b32cb0d8865059815b8235d4297abbabd0cb963</cites><orcidid>0000-0003-0818-1232</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281224/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281224/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37339353$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liu, Liu</creatorcontrib><creatorcontrib>Wess, Jürgen</creatorcontrib><title>Adipocyte G Protein-Coupled Receptors as Potential Targets for Novel Antidiabetic Drugs</title><title>Diabetes (New York, N.Y.)</title><addtitle>Diabetes</addtitle><description>The functional state of adipocytes plays a central role in regulating numerous important metabolic functions, including energy and glucose homeostasis. While white adipocytes store excess calories as fat (triglycerides) and release free fatty acids as a fuel source in times of need, brown and beige adipocytes (so-called thermogenic adipocytes) convert chemical energy stored in substrates (e.g., fatty acids or glucose) into heat, thus promoting energy expenditure. Like all other cell types, adipocytes express many G protein-coupled receptors (GPCRs) that are linked to four major functional classes of heterotrimeric G proteins (Gs, Gi/o, Gq/11, and G12/13). During the past few years, novel experimental approaches, including the use of chemogenetic strategies, have led to a series of important new findings regarding the metabolic consequences of activating or inhibiting distinct GPCR/G protein signaling pathways in white, brown, and beige adipocytes. This novel information should guide the development of novel drugs capable of modulating the activity of specific adipocyte GPCR signaling pathways for the treatment of obesity, type 2 diabetes, and related metabolic disorders.</description><subject>Adipocytes</subject><subject>Adipocytes, Beige - metabolism</subject><subject>Adipocytes, Brown - metabolism</subject><subject>Adipocytes, White - metabolism</subject><subject>Antidiabetics</subject><subject>Calories</subject><subject>Diabetes</subject><subject>Diabetes mellitus (non-insulin dependent)</subject><subject>Diabetes Mellitus, Type 2 - drug therapy</subject><subject>Diabetes Mellitus, Type 2 - metabolism</subject><subject>Drug development</subject><subject>Energy expenditure</subject><subject>Energy Metabolism</subject><subject>Fatty acids</subject><subject>G protein-coupled receptors</subject><subject>Glucose - metabolism</subject><subject>Homeostasis</subject><subject>Humans</subject><subject>Hypoglycemic Agents - metabolism</subject><subject>Hypoglycemic Agents - pharmacology</subject><subject>Hypoglycemic Agents - therapeutic use</subject><subject>Metabolic disorders</subject><subject>Metabolism</subject><subject>Precision medicine</subject><subject>Proteins</subject><subject>Receptors, G-Protein-Coupled - metabolism</subject><subject>s in Diabetes</subject><subject>Signal transduction</subject><subject>Thermogenesis</subject><subject>Triglycerides</subject><issn>0012-1797</issn><issn>1939-327X</issn><issn>1939-327X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkUtLxDAUhYMoOj4W_gEJuNFFNcntI1nJMD5BVGREdyFJ0zHSaWrSCv57O46KShZ3cT4OJ3wI7VJyxACK41IzSAgR2QoaUQEiAVY8raIRIZQltBDFBtqM8YUQkg9vHW1AASAggxF6HJeu9ea9s_gC3wXfWdckE9-3tS3xvTW27XyIWEV8N2RN51SNpyrMbBdx5QO-8W-2xuMhKJ3StnMGn4Z-FrfRWqXqaHe-7hZ6OD-bTi6T69uLq8n4OjEpSbtE5KxSIEzFDE8JVZwzYY3KgWpgRpOS8zwjmeA005xBVqZMFEprpUtitMhhC50se9tez21pholB1bINbq7Cu_TKyb9J457lzL9JShinjKVDw8FXQ_CvvY2dnLtobF2rxvo-SsYZhxyyYoHu_0NffB-a4X-flKBQcDFQh0vKBB9jsNXPGkrkwpdc-JILXwO793v-D_ktCD4AHGmQSw</recordid><startdate>20230701</startdate><enddate>20230701</enddate><creator>Liu, Liu</creator><creator>Wess, Jürgen</creator><general>American Diabetes Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0818-1232</orcidid></search><sort><creationdate>20230701</creationdate><title>Adipocyte G Protein-Coupled Receptors as Potential Targets for Novel Antidiabetic Drugs</title><author>Liu, Liu ; Wess, Jürgen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c404t-962fa39cf2c8401a8829eca631b32cb0d8865059815b8235d4297abbabd0cb963</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Adipocytes</topic><topic>Adipocytes, Beige - metabolism</topic><topic>Adipocytes, Brown - metabolism</topic><topic>Adipocytes, White - metabolism</topic><topic>Antidiabetics</topic><topic>Calories</topic><topic>Diabetes</topic><topic>Diabetes mellitus (non-insulin dependent)</topic><topic>Diabetes Mellitus, Type 2 - drug therapy</topic><topic>Diabetes Mellitus, Type 2 - metabolism</topic><topic>Drug development</topic><topic>Energy expenditure</topic><topic>Energy Metabolism</topic><topic>Fatty acids</topic><topic>G protein-coupled receptors</topic><topic>Glucose - metabolism</topic><topic>Homeostasis</topic><topic>Humans</topic><topic>Hypoglycemic Agents - metabolism</topic><topic>Hypoglycemic Agents - pharmacology</topic><topic>Hypoglycemic Agents - therapeutic use</topic><topic>Metabolic disorders</topic><topic>Metabolism</topic><topic>Precision medicine</topic><topic>Proteins</topic><topic>Receptors, G-Protein-Coupled - metabolism</topic><topic>s in Diabetes</topic><topic>Signal transduction</topic><topic>Thermogenesis</topic><topic>Triglycerides</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liu, Liu</creatorcontrib><creatorcontrib>Wess, Jürgen</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Diabetes (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Liu</au><au>Wess, Jürgen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adipocyte G Protein-Coupled Receptors as Potential Targets for Novel Antidiabetic Drugs</atitle><jtitle>Diabetes (New York, N.Y.)</jtitle><addtitle>Diabetes</addtitle><date>2023-07-01</date><risdate>2023</risdate><volume>72</volume><issue>7</issue><spage>825</spage><epage>834</epage><pages>825-834</pages><issn>0012-1797</issn><issn>1939-327X</issn><eissn>1939-327X</eissn><abstract>The functional state of adipocytes plays a central role in regulating numerous important metabolic functions, including energy and glucose homeostasis. While white adipocytes store excess calories as fat (triglycerides) and release free fatty acids as a fuel source in times of need, brown and beige adipocytes (so-called thermogenic adipocytes) convert chemical energy stored in substrates (e.g., fatty acids or glucose) into heat, thus promoting energy expenditure. Like all other cell types, adipocytes express many G protein-coupled receptors (GPCRs) that are linked to four major functional classes of heterotrimeric G proteins (Gs, Gi/o, Gq/11, and G12/13). During the past few years, novel experimental approaches, including the use of chemogenetic strategies, have led to a series of important new findings regarding the metabolic consequences of activating or inhibiting distinct GPCR/G protein signaling pathways in white, brown, and beige adipocytes. This novel information should guide the development of novel drugs capable of modulating the activity of specific adipocyte GPCR signaling pathways for the treatment of obesity, type 2 diabetes, and related metabolic disorders.</abstract><cop>United States</cop><pub>American Diabetes Association</pub><pmid>37339353</pmid><doi>10.2337/db23-0095</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0003-0818-1232</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0012-1797 |
ispartof | Diabetes (New York, N.Y.), 2023-07, Vol.72 (7), p.825-834 |
issn | 0012-1797 1939-327X 1939-327X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10281224 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Adipocytes Adipocytes, Beige - metabolism Adipocytes, Brown - metabolism Adipocytes, White - metabolism Antidiabetics Calories Diabetes Diabetes mellitus (non-insulin dependent) Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - metabolism Drug development Energy expenditure Energy Metabolism Fatty acids G protein-coupled receptors Glucose - metabolism Homeostasis Humans Hypoglycemic Agents - metabolism Hypoglycemic Agents - pharmacology Hypoglycemic Agents - therapeutic use Metabolic disorders Metabolism Precision medicine Proteins Receptors, G-Protein-Coupled - metabolism s in Diabetes Signal transduction Thermogenesis Triglycerides |
title | Adipocyte G Protein-Coupled Receptors as Potential Targets for Novel Antidiabetic Drugs |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T12%3A29%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adipocyte%20G%20Protein-Coupled%20Receptors%20as%20Potential%20Targets%20for%20Novel%20Antidiabetic%20Drugs&rft.jtitle=Diabetes%20(New%20York,%20N.Y.)&rft.au=Liu,%20Liu&rft.date=2023-07-01&rft.volume=72&rft.issue=7&rft.spage=825&rft.epage=834&rft.pages=825-834&rft.issn=0012-1797&rft.eissn=1939-327X&rft_id=info:doi/10.2337/db23-0095&rft_dat=%3Cproquest_pubme%3E2828913789%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2828913789&rft_id=info:pmid/37339353&rfr_iscdi=true |